Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kairos Ventures is a venture capital firm founded in 2015, based in Beverly Hills, California. The organization focuses on supporting and commercializing scientific discoveries emerging from leading universities and scientists. With a hands-on approach, Kairos Ventures invests early in the development stages of companies, providing not only capital but also strategic support through a network of professionals across various disciplines.
Currently, the firm manages a portfolio of over 51 active companies and operates regional offices in Pasadena, New York, Washington D.C., and Austin. The firm has a team of 15 professionals, including five partners, and emphasizes collaboration with scientists to transform innovative ideas into impactful businesses. Notable milestones include the successful backing of Mammoth Biosciences, a unicorn in CRISPR diagnostics, and several other significant exits.
Kairos Ventures primarily invests in early-stage companies within the life sciences and physical sciences sectors. The firm targets investments ranging from $150,000 to $20 million, depending on the venture's development stage and capital requirements. Their investment strategy centers on backing world-class scientists and entrepreneurs, focusing on ideas and patents emerging from top universities. The firm is particularly interested in biotech, healthcare, frontier technologies, artificial intelligence, and fintech.
Investment stages include pre-seed, seed, seed-plus (extension), and Series A. Kairos Ventures seeks to partner with founders who demonstrate a strong vision and the capability to execute their ideas. The firm values scientific rigor and innovation, aiming to transform groundbreaking discoveries into viable commercial entities.
Kairos Ventures boasts a diverse portfolio of over 51 active companies, showcasing a strong presence in the life sciences and physical sciences sectors. Notable portfolio companies include:
Jim Demetriades: CEO and Founder of Kairos Ventures, with a background in venture capital and a focus on scientific commercialization.
Todd Thomson: Chief Operating and Financial Officer, responsible for financial strategy and operations.
Alex Andrianopoulos: Chief R&D Officer, overseeing research and development initiatives within the portfolio.
Paul Becker: Financial Controller, managing financial reporting and compliance.
Josh Palmer, PhD: Principal, Physical Sciences Investments, with expertise in physical sciences and technology investments.
Richard Lynch: Manager of Finance, handling financial operations and analysis.
David Park: Executive in Residence, providing strategic guidance to portfolio companies.
George Lauro: Board Partner, contributing to strategic decision-making and governance.
Stephanie Kawecki, PhD: Investment Associate, Life Sciences, focusing on investments in the life sciences sector.
To pitch to Kairos Ventures, founders should visit their contact page at kairosventures.com/contact or email info@kairosventures.com. The pitch deck should include a clear overview of the business model, market opportunity, and team background. Kairos Ventures prefers warm introductions but is open to direct applications.
Response times can vary, but founders should expect to hear back within a few weeks after submission. Providing detailed information about the scientific basis of the startup and its potential impact is essential.
In March 2026, Kairos Ventures highlighted significant advancements in its portfolio companies through blog posts covering strategic partnerships and conference presentations. The firm actively promotes its portfolio, showcasing the progress and innovations of its investments.
Recent updates include presentations at major industry conferences and collaborations with other organizations, emphasizing the firm's commitment to supporting its portfolio companies in their growth journeys.
What are Kairos Ventures' investment criteria?
Kairos Ventures invests in early-stage companies primarily in the life sciences and physical sciences sectors. They look for innovative ideas and patents emerging from leading universities and scientists.
How can I apply or pitch to Kairos Ventures?
Founders can apply for investment by visiting the contact page on the Kairos Ventures website at kairosventures.com/contact or by emailing info@kairosventures.com.
What makes Kairos Ventures different from other venture capital firms?
Kairos Ventures emphasizes a hands-on approach, providing not only capital but also strategic support through a network of experienced professionals. This model helps portfolio companies navigate the complexities of commercialization.
What is the geographic scope of Kairos Ventures?
The firm primarily invests in companies based in the United States, focusing on scientific innovations that emerge from top universities.
What is the typical check size for investments?
Kairos Ventures typically invests between $150,000 and $20 million, depending on the stage of the company and its capital requirements.
What is the firm's involvement post-investment?
Kairos Ventures actively supports its portfolio companies through mentorship, operational support, and access to a network of professionals, enhancing their growth trajectory.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.